Department of Surgery (A), Heinrich-Heine-University and University Hospital Duesseldorf, Moorenstr. 5, 40225, Duesseldorf, Germany.
Institute of Pathology, Heinrich-Heine-University and University Hospital Duesseldorf, Moorenstr. 5, 40225, Duesseldorf, Germany.
Pancreatology. 2021 Jun;21(4):787-795. doi: 10.1016/j.pan.2021.02.024. Epub 2021 Mar 17.
Survival in ductal adenocarcinoma of the pancreatic head (hPDAC) is poor. After implementation of the circumferential resection margin (CRM) into standard histopathological evaluation, the margin negative resection rate has drastically dropped. However, the impact of surgical radicality on survival and the influence of malignant infiltration of the mesopancreatic fat remains unclear. At our institution, a standardized dissection of the mesopancreatic lamina and peri-pancreatic vessels are obligatory components of radical pancreatoduodenectomy. The aim of our study was to histopathologically analyze mesopancreatic tumor infiltration and the influence of CRM-evaluated resection margin on relapse-free and overall survival.
Clinicopathological and survival parameters of 264 consecutive patients who underwent surgery for hPDAC were evaluated.
The rate of R0 resection R0(CRM-) was 48.5%, after the implementation of CRM. Mesopancreatic fat infiltration was evident in 78.4% of all consecutively treated patients. Patients with mesopancreatic fat infiltration were prone to lymphatic metastases (N1 and N2) and had a higher rate of positive resection margin (R1/R0(CRM+)). In multivariate analysis, only R0 resection was shown to be an independent prognostic parameter. Local recurrence was diagnosed in only 21.1% and was significantly lower in patients with R0(CRM-) resected hPDACs (10.9%, p < 0.001).
Mesopancreatic excision is justified, since mesopancreatic fat invasion was evident in the majority of our patients. It is associated with a significantly improved local tumor control as well as longer relapse-free and overall survival.
胰头导管腺癌(hPDAC)患者的生存率较差。在将环周切缘(CRM)纳入标准组织病理学评估后,阴性切缘的切除率大幅下降。然而,手术根治性对生存的影响以及中胰腺脂肪恶性浸润的影响仍不清楚。在我们的机构,对中胰腺层和胰周血管的标准化解剖是根治性胰十二指肠切除术的强制性组成部分。我们研究的目的是从组织病理学上分析中胰腺肿瘤浸润以及 CRM 评估的切缘对无复发生存和总生存的影响。
评估了 264 例连续接受 hPDAC 手术治疗的患者的临床病理和生存参数。
实施 CRM 后,R0 切除率(R0(CRM-))为 48.5%。在所有连续治疗的患者中,有 78.4%的患者中胰腺脂肪浸润明显。中胰腺脂肪浸润的患者易发生淋巴转移(N1 和 N2),且阳性切缘(R1/R0(CRM+))的发生率更高。多因素分析显示,只有 R0 切除是独立的预后参数。仅诊断出 21.1%的局部复发,在接受 R0(CRM-)切除的 hPDAC 患者中明显更低(10.9%,p<0.001)。
中胰腺切除术是合理的,因为在我们的大多数患者中,中胰腺脂肪浸润明显。它与明显改善的局部肿瘤控制以及更长的无复发生存和总生存相关。